Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
about
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.Animal models for bladder cancer: The model establishment and evaluation (Review).Dacomitinib for the treatment of advanced or metastatic non-small-cell lung cancer.Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
P2860
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
@en
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.
@nl
type
label
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
@en
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.
@nl
prefLabel
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
@en
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.
@nl
P2093
P2860
P1433
P1476
Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer
@en
P2093
Alyssa Paul
Andreas Karatsinides
Dafydd Thomas
Iya Owainati
Kathleen C Day
Lakshmi P Kunju
Maha Hussain
Mark L Day
Monica Liebert
Nazia Shakir
P2860
P2888
P304
P356
10.2119/MOLMED.2013.00108
P407
P577
2013-11-08T00:00:00Z
P5875
P6179
1068965627